Here at Harbor-UCLA, we treat many patients with scleroderma-associated PAH, as well as other related "connective tissue" disorders. Results have shown that patients can benefit from Flolan, Remodulin, and Tracleer, in spite of their underlying disorder. This means that patients with certain forms of secondary PAH can be treated in the same fashion as PPH patients.
If there are any questions, please call our research nurse, Joy Beckmann or her associates at (310)-222-3560 or visit the

Scleroderma foundation

You can also jump to the:
Southern California Chapter of the Scleroderma Foundation